New User? Sign Up | Sign In

Sec Form 4 Filing - Smith Michael P. @ Ingevity Corp - 2021-02-18

  1. About Form 4 Filing: Every director, officer or owner of more than ten percent of a class of equity securities registered under Section 12 of the '34 Act must file with the U.S. Securities and Exchange Commission (SEC) a statement of ownership regarding such security. The initial filing is on Form 3 and changes are reported on Form 4. The Annual Statement of beneficial ownership of securities is on Form 5. The forms contain information on the reporting person's relationship to the company and on purchases and sales of such equity securities.
  2. Form 4 is stored in SEC's EDGAR database. EDGAR is Electronic Data Gathering, Analysis and Retrieval System. It is a registered trademark of the SEC.

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Email a friend >>...

SPAC List: List of Special Purpose Acquisition Companies


The following is an SEC EDGAR document rendered as filed.
Here is the list of insider trading transaction codes.

FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person *
Smith Michael P.
2. Issuer Name and Ticker or Trading Symbol
Ingevity Corp [ NGVT]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
EVP, President Perf Chemicals
(Last)
(First)
(Middle)
4920 O'HEAR AVE, SUITE 400
3. Date of Earliest Transaction (MM/DD/YY)
02/18/2021
(Street)
NORTH CHARLESTON, SC29405
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/18/2021 A 3,613 ( 1 ) A $ 0 23,216 D
Common Stock 02/18/2021 F 1,173 ( 2 ) D $ 69.18 22,043 D
Common Stock 02/26/2021 A 2,129 ( 3 ) A $ 0 24,172 D
Common Stock 02/28/2021 F 154 ( 4 ) D $ 69.345 24,018 D
Common Stock 02/28/2021 F 1,047 ( 4 ) D $ 69.345 22,971 D
Common Stock 02/28/2021 F 118 ( 5 ) D $ 69.345 22,853 D
Common Stock 02/28/2021 F 344 ( 6 ) D $ 69.345 22,509 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right-to-buy) $ 32.05 02/26/2021 A 4,614 ( 7 ) 02/26/2022 02/26/2031 Common Stock 4,614 $ 0 4,614 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Smith Michael P.
4920 O'HEAR AVE
SUITE 400
NORTH CHARLESTON, SC29405
EVP, President Perf Chemicals
Signatures
/s/ Michael P. Smithby Stacy L. Cozad as Attorney-in-Fact 03/02/2021
** Signature of Reporting Person Date
Explanation of Responses:
( 1 )On February 18, 2021, the Leadership Development and Compensation Committee certified the attainment of the performance goals for certain performance-based restricted stock awards ("PSUs"). The PSUs were settled with shares of common stock.
( 2 )Shares withheld by the Company to satisfy tax withholding obligations related to the PSUs that vested on February 18, 2021.
( 3 )Grant of restricted stock units pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan, which will vest in three equal installments on February 26, 2022, 2023, and 2024.
( 4 )Shares withheld by the Company to satisfy tax withholding obligations related to the 2018 RSUs that vested on February 28, 2021.
( 5 )Shares withheld by the Company to satisfy tax withholding obligations related to the 2019 RSUs that vested on February 28, 2021.
( 6 )Shares withheld by the Company to satisfy tax withholding obligations related to the 2020 RSUs that vested on February 28, 2021.
( 7 )These options are granted pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan. Such options will vest ratably beginning February 26, 2022, 2023 and 2024.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.